The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  Monogram Biosciences Inc. (MGRM)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Cutting loss

May 10, 2007 06:41 PM GMT
Return Risk
-8.35% HIGH
Sr. Analyst

I still like the company long term, but going out for now.  there's lack of catalyst in the ext yr or so.  The closest I think is the increased revenue from Trofile/CCR5 Maraviroc tie in.  In the long term, the cancer assays have the biggest potentials, but investors have to be really patient for it.

MGRM:  This call was made on 05/10/07 @ $9.78
Rating:   Negative   $9.78 (05/10/07)
Closed:   05/17/2007 @ $9.6 (+1.84% in 7 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
GOOG Google Inc
BIDU Baiducom Inc ADS
MO Altria Group Inc
JPM JPMorgan Chase & Co
GE General Electric Company
POT Potash Corp. of Saskatchewan Inc.

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Monogram Biosciences Inc. (MGRM)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
92.5%
Top:
100.0%




Latest Picks by kuntilanak
Symbol SP Sentiment Rating Return Since
HDNG Positive -87.72% 07/18/07
NTAP Positive +3.58% 07/18/07
DIVX Positive -68.20% 05/23/07
CHINA Positive -70.83% 05/23/07
SNDA Positive +77.02% 05/23/07

View All >
   
kuntilanak previously rated MGRM
Positive -35.83% Potential Upside with Trofile/Maraviroc
04/20/2007
7
Positive +38.04% Potential upsode with Trofile/Maraviroc
04/16/2007
1





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch